Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.21 | 4e-05 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |